Cargando…
Integrative chemogenomic analysis identifies small molecules that partially rescue ΔF508‐CFTR for cystic fibrosis
Rare diseases affect 10% of the first‐world population, yet over 95% lack even a single pharmaceutical treatment. In the present age of information, we need ways to leverage our vast data and knowledge to streamline therapeutic development and lessen this gap. Here, we develop and implement an innov...
Autores principales: | Hodos, Rachel A., Strub, Matthew D., Ramachandran, Shyam, Meleshkevitch, Ella A., Boudko, Dmitri Y., Bridges, Robert J., Dudley, Joel T., McCray, Paul B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129714/ https://www.ncbi.nlm.nih.gov/pubmed/33934548 http://dx.doi.org/10.1002/psp4.12626 |
Ejemplares similares
-
Integrative genomic meta-analysis reveals novel molecular insights into cystic fibrosis and ΔF508-CFTR rescue
por: Hodos, Rachel A., et al.
Publicado: (2020) -
Translating in vitro CFTR rescue into small molecule correctors for cystic fibrosis using the Library of Integrated Network‐based Cellular Signatures drug discovery platform
por: Strub, Matthew D., et al.
Publicado: (2021) -
Analysis of multiple gene co-expression networks to discover interactions favoring CFTR biogenesis and ΔF508-CFTR rescue
por: Strub, Matthew D., et al.
Publicado: (2021) -
ΔF508 CFTR interactome remodeling promotes rescue of Cystic Fibrosis
por: Pankow, Sandra, et al.
Publicado: (2015) -
Molecular Structures Reveal Synergistic Rescue of Δ508 CFTR by Trikafta Modulators
por: Fiedorczuk, Karol, et al.
Publicado: (2022)